BÜBL™ WINS BRONZE LION This year, Osteoporosis Canada launched a transformative campaign intended to disrupt the osteoporosis landscape, while shining a light on a disease that affects 2 million […]

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

SAC Members and Research MD, MSC, PHD AhmedNegm Dr. Ahmed Negm is a trained orthopedic surgeon with additional training in health research and rehabilitation sciences. Following his undergraduate medical training […]

HORMONE THERAPY (HT) Estrogen plays such an important role in maintaining bone. Hormone Therapy (HT) or estrogen/progesterone, is commonly used to relieve the symptoms of menopause. However, because estrogen plays […]

No link between the use of bisphosphonates and the risk of cancer of the esophagus or stomach has also been noted in a recent large study from the UK. This […]

Osteoporosis Canada is pleased to share that long-time volunteer Dr. Hilary Jaeger is one of three leaders recognized as Honorary Fellows of the Royal College for her transformative contributions to […]

We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

Volunteer Become an Osteoporosis Canada Volunteer Osteoporosis Canada is the only national organization serving people affected by osteoporosis. The organization works to educate, empower and support individuals and communities on […]

Accessibility Accessibility Accessibility for Ontarians With Disabilities Act (AODA) Accessibility for Ontarians With Disabilities Act (AODA) Osteoporosis Canada is committed to excellence in servicing all customers including people with disabilities. […]